AzTrials
AzTrials

Skin ConditionNCT05277324

The Effect of Wearing Facial Masks on Skin Parameters During the COVID-19 Pandemic

An observational study of Skin Condition and Skin Inflammation, run by University of Split, School of Medicine at 1 site in Croatia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The global coronavirus disease pandemic (COVID-19) has led to an increased need to wear protective equipment such as wearing face masks and practicing hygiene measures such as more frequent use of antiseptics. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Protective facial mask
How many people
20 participants
Where
1 siteCroatia
Study dates
7 Mar 2022to 31 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Adult, Older adult

Study population: Healthy students of health related professions who wear facial mask daily for at least six hours durnig their internship/practice in health care institutions.

Who may be able to join

  • young, healthy volunteers who gave written informed consent - students of health related professions who wear facial mask for at least six hours a day durnig their internship/practice in health care institutions

Who cannot join

  • skin disease, skin damage on measurement sites
  • use of corticosteroids, antihistamines and immunomodulators a month prior the inclusion and during the trial
  • use of emollients three days prior the inclusion in the trial
  • non-adherence to the trial protocol
  • exposure to artificial and excessive natural UV radiation
  • pregnancy and lactation
  • skin cancer
  • immunosuppression

Trial locations and contacts

1 site in 1 country.

Dario Leskur, PhD, MPharm contact

+38521557851

dario.leskur@mefst.hr

Croatia1 site, 1 recruiting
  • University of Split School of Medicine

    Split, 21000

    Dario Leskur, PhD, MPharm, +38521557851, dario.leskur@mefst.hr

    Recruiting

Other trials in Croatia

About this study

The global coronavirus disease pandemic (COVID-19) has led to an increased need to wear protective equipment such as wearing face masks and practicing hygiene measures such as more frequent use of antiseptics. These measures can lead to changes in the skin, the development of new inflammatory skin diseases or exacerbation of existing ones, with health professionals especially under the risk of developing these changes. Changes in facial skin due to wearing masks have been observed in a number of studies, however, part of the study was based solely on subjects' self-assessment or clinical assessment, and only a small part on objective measurements of skin parameters. Also, the impact of prolonged masks' use have not been investigated.

The aim of these study was to investigate the effects of constant, long-term use of protective masks on facial skin.

Being tested
Protective facial mask
Medical subject headings
Skin Diseases, Dermatitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protective facial maskOther

    Participants, students of health related professions, who wear protective facial mask daily during their internship/practice in health institutions.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Transepidermal water loss change

    Tewameter will be used to assess skin barrier function as a measurement of the water loss (g/hm2).

    Measured: Weekly measurements for the duration of six weeks

  2. Stratum corneum hydration change

    Corneometer will be used to estimate skin dryness. It is a relative measurement and uses arbitrary units (AU).

    Measured: Weekly measurements for the duration of six weeks

  3. Skin erythema change

    Mexameter will be used to assess erythema. It is a relative measurement and uses arbitrary units (AU).

    Measured: Weekly measurements for the duration of six weeks

  4. Melanin content change

    Mexameter will be used to assess skin melanin content. It is a relative measurement and uses arbitrary units (AU).

    Measured: Weekly measurements for the duration of six weeks

  5. Participants' reported facial skin changes

    Structured interview to determine if participants developed adverse events related to mask wearing (such as dryness, erythema, rash, scaling, pruritus, pain/burning, changes in texture or colour, ulcers etc.) between two measurement time-points.

    Measured: Weekly measurements for the duration of six weeks

  6. Sebum level changes

    Sebumeter will be used to assess sebum levels. It is a relative measurement and uses arbitrary units (AU).

    Measured: Weekly measurements for the duration of six weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2022
  2. Study start7 Mar 2022
  3. Primary completion31 May 2022 (estimated)
  4. Study completion31 May 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05277324
Sponsor's protocol ID
2181-198-03-04-22-0010
Status last verified
Mar 2022
First submitted
10 Mar 2022
Last updated
29 Mar 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Montero-Vilchez T, Cuenca-Barrales C, Martinez-Lopez A, Molina-Leyva A, Arias-Santiago S. Skin adverse events related to personal protective equipment: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1994-2006. doi: 10.1111/jdv.17436. Epub 2021 Jun 29.

    PubMed 34077565
  • Park SR, Han J, Yeon YM, Kang NY, Kim E. Effect of face mask on skin characteristics changes during the COVID-19 pandemic. Skin Res Technol. 2021 Jul;27(4):554-559. doi: 10.1111/srt.12983. Epub 2020 Nov 20.

    PubMed 33217053
  • Elston DM. Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic. J Am Acad Dermatol. 2020 May;82(5):1085-1086. doi: 10.1016/j.jaad.2020.03.012. Epub 2020 Mar 18. No abstract available.

    PubMed 32171807
  • Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol. 2021 Oct;20(10):3105-3115. doi: 10.1111/jocd.14266. Epub 2021 Jul 1.

    PubMed 34077629

Questions about this trial

What is this clinical trial studying?

An observational study of Skin Condition and Skin Inflammation, run by University of Split, School of Medicine at 1 site in Croatia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dario Leskur, PhD, MPharm (+38521557851, dario.leskur@mefst.hr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Transepidermal water loss change (time frame: Weekly measurements for the duration of six weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05277324, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in